OSE Immunotherapeutics (LTS:0RAD) Other Income (Expense) : €-0.84 Mil (TTM As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Other Income (Expense)?

OSE Immunotherapeutics's other income expense for the OSE Immunotherapeutics's pretax income for the six months ended in Jun. 2024 was €-0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.84 Mil.

OSE Immunotherapeutics Other Income (Expense) Historical Data

The historical data trend for OSE Immunotherapeutics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Other Income (Expense) Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

0.12

0.01

0.24

1.73

1.76

OSE Immunotherapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Income (Expense)	Get a 7-Day Free Trial															1.95	-0.22	2.60	-0.84	-

OSE Immunotherapeutics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.84 Mil.

OSE Immunotherapeutics (LTS:0RAD) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

OSE Immunotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (LTS:0RAD) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

OSEp:UK OSE:France 6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics Headlines

No Headlines